Loading clinical trials...
Loading clinical trials...
To compare mechanic and thermic stability of pericardium fixated either with 0.6% glutaraldehyde for 10 minutes or with 0.6% glutaraldehyde for 20 minutes
Autologous pericardium for aortic valve reconstruction is treated with 0.6% glutaraldehyde for 10 minutes to improve stability (OKAZI technique). This study investigates whether treatment with 0.6% glutaraldehyde for 20 minutes improves mechanic and thermic stability of autologous pericardial tissue. Autologous pericardium remaining after aortic valve reconstruction surgery is used. To investigate 10 versus 20 minutes treatment of removed original aortic valve tissue with glutaraldehyde as a reference.
Age
All ages
Sex
ALL
Healthy Volunteers
No
Herzchirurgie University Hospital Basel
Basel, Switzerland
Start Date
August 4, 2017
Primary Completion Date
October 31, 2019
Completion Date
October 31, 2019
Last Updated
December 10, 2019
6
ACTUAL participants
Treatment of human pericardium with glutaraldehyde in OZAKI procedure
OTHER
Treatment of human aortic valve tissue with glutaraldehyde
OTHER
Lead Sponsor
University Hospital, Basel, Switzerland
NCT07212842
NCT03079830
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions